| 1 |
How does the concept of “model as a dataset” reshape traditional data-sharing practices in medical imaging?
|
3. It enables sharing of learned model weights instead of sensitive raw images. |
|
แนวคิด “model as a dataset” หมายถึงการใช้ โมเดลที่เรียนรู้จากข้อมูลแทนการใช้ข้อมูลดิบจริง แทนที่จะแชร์ ภาพทางการแพทย์ดิบที่อาจละเมิดความเป็นส่วนตัวของผู้ป่วย นักวิจัยสามารถแชร์ น้ำหนัก (weights) ของโมเดลที่ได้รับการฝึกฝนแล้ว |
ข้ออื่น ๆ ไม่ถูกต้องเพราะ:
1.ยังต้องผ่านข้อกำกับดูแลตามกฎหมาย
2.ไม่ได้แทนที่ด้วยข้อความทั้งหมด
3.ไม่จำเป็นต้องเปิดเผยข้อมูลผู้ป่วย
4.โมเดลสามารถนำไปใช้ซ้ำในหลายสถาบัน |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which analytical conclusion can be drawn about the trade-offs between physics-informed and statistical models?
|
2. Physics-informed models are more interpretable but computationally intensive. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
Why is “mode collapse” considered a critical problem in GAN-based medical image synthesis?
|
2. It reduces image realism and variety by producing repetitive outputs. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Why are healthcare-specific metrics preferred over general-purpose metrics such as FID or SSIM?
|
2. They better capture clinical accuracy and diagnostic relevance. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What does the article identify as the key tension between privacy preservation and image fidelity?
|
1. Higher realism may risk reproducing identifiable patient data. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
Why is the FDA’s approval of synthetic MRI technology significant for future AI-generated data?
|
1. It establishes a framework for validating synthetic data equivalence in clinical use. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
Which strategy would best mitigate demographic bias in generative models according to the article?
|
2. Applying diversity-aware training and fairness constraints |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
How do DDPMs exemplify versatility in healthcare image synthesis?
|
2. They can perform multiple tasks such as denoising, inpainting, and anomaly detection without retraining. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
What analytical insight does the article provide about integrating AI-generated medical images into education and research?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
Why is regional calibration essential when applying risk prediction models across countries?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What analytical conclusion can be drawn when comparing the China-PAR and Framingham models?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Based on CVD mortality data, what analytical inference can be made about Japan’s position compared to neighboring countries?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What analytical limitation arises when using Western-derived coefficients in East Asian models?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What policy implication can be derived from country-specific risk models?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
If a model excludes socioeconomic variables, what analytical consequence might occur?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
How might AI improve next-generation ASCVD risk prediction in East Asia?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What conclusion can be drawn from comparing Mongolia’s and South Korea’s CVD mortality rates?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What is the most logical future direction for improving ASCVD models across East Asia?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
According to the “image generation trilemma” shown in the figure, what analytical conclusion can be drawn about the relative strengths of VAEs, GANs, and DDPMs in medical image synthesis?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
Based on Figure, what analytical conclusion can be drawn regarding the distribution of cardiovascular disease (CVD) subtypes across East Asian countries?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|